NASDAQ
CollPlant Biotechnologies Ltd. (CLGN) has a free cash flow growth of 5.30% as of Friday, May 29, 2026. This represents a 129.87% increase compared to its 12-month average of -17.76%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.